Corvus Pharmaceuticals, Inc.·4

Sep 28, 5:45 PM ET

MILLER RICHARD A MD 4

4 · Corvus Pharmaceuticals, Inc. · Filed Sep 28, 2022

Insider Transaction Report

Form 4
Period: 2022-09-28
MILLER RICHARD A MD
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-09-28$0.76/sh+25,000$19,0701,394,405 total(indirect: By Trust)
Holdings
  • Common Stock

    35,714
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7425 to $0.79, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4